GLUE
Monte Rosa Therapeutics Inc
11.70$
-1.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
Monte Rosa Therapeutics Inc (GLUE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -81 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -25 | 30 | -38 | -28 | -21 | 129 | -45 | -35 | 100 | -43 | -37 | -81 | -61 | |
| 1.8 | 1.8 | 1.9 | 2.1 | 2.1 | 2.1 | 2.0 | 2.1 | 2.1 | 2.1 | 2.0 | 3.9 | 10 | |
| 4.5 | 4.1 | 4.9 | 4.5 | 4.3 | 4.5 | 5.3 | 4.9 | 4.4 | 4.3 | 5.9 | 12 | 27 | |
| 4.4 | 58 | -13 | -2.9 | -2.4 | 110 | -99 | -29 | 122 | -3.4 | 0.1 | -7.6 | 111 | |
| 1.7 | 1.7 | 1.4 | 2.0 | 0.4 | 0.2 | 1.6 | 1.7 | 0.7 | 0.8 | 1.9 | 6.6 | 9.9 | |
| 36 | 14 | 9.9 | -61 | 38 | -31 | -100 | 25 | 38 | -65 | -261 | -290 | -578 | |
| – | – | – | – | – | 0.0 | – | – | – | -0.4 | – | – | – | |
| 1.1 | 25 | 0.2 | 98 | 0.0 | 0.6 | 0.0 | 0.4 | 0.3 | 30 | 328 | 332 | 690 | |
| 12 | 69 | -28 | 9.1 | 17 | 99 | -146 | -9.0 | 139 | -78 | 30 | -40 | 51 | |
| -26 | 28 | -40 | -30 | -21 | 129 | -47 | -36 | 100 | -44 | -39 | -88 | -71 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.